Medical Device Procurement in Mexico: A Supplier's Guide [2026]

Mexico is the second-largest medical device market in Latin America, valued at approximately USD 7 billion. With a population of 130 million, major public health insurance systems (IMSS, ISSSTE, INSABI/IMSS-Bienestar), and proximity to the United States, Mexico offers significant procurement opportunities. COFEPRIS regulatory requirements, centralized public procurement through CompraNet, and the USMCA trade framework shape the commercial landscape for medical device suppliers.

Regulatory authority and approval pathway

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) regulates medical devices under the General Health Law and its regulations:

• Device classification: Mexico classifies devices into three classes (I, II, III) based on risk.
• Sanitary registration (Registro Sanitario): Class II and III devices require pre-market sanitary registration from COFEPRIS. Class I devices require listing notification.
• Manufacturing license: Importers and distributors must hold a Health License (Licencia Sanitaria) from COFEPRIS.
• GMP compliance: COFEPRIS conducts manufacturing facility inspections. For foreign manufacturers, COFEPRIS auditors may visit production sites — though the agency increasingly accepts MDSAP audit reports.
• Labeling: Device labeling must comply with NOM-137-SSA1 (Mexican Official Standard for medical device labeling) and be in Spanish.

COFEPRIS processing times have improved but can still extend to 12-18 months for Class III devices. Early engagement and complete submissions reduce delays.

Key procurement platforms and channels

• CompraNet: Mexico's federal government electronic procurement portal. All federal public sector tenders, including IMSS and ISSSTE hospital procurement, are published on CompraNet.
• IMSS (Mexican Social Security Institute): The largest healthcare provider, covering over 80 million beneficiaries. IMSS consolidated procurement represents the single largest device purchasing entity in Mexico.
• ISSSTE: Provides healthcare to government employees and runs its own procurement programs.
• INSABI/IMSS-Bienestar: Government program providing coverage to the uninsured population, with procurement increasingly consolidated under IMSS-Bienestar.
• Private hospital groups: Grupo Angeles, Christus Muguerza, Star Medica, and other private systems conduct independent procurement.

Compliance requirements for tenders

• Valid COFEPRIS registration: Mandatory for all public and private procurement.
• Spanish-language documentation: All submissions, labeling, IFU, and training materials must be in Spanish.
• NOM compliance: Devices must meet applicable Mexican Official Standards (NOMs) — particularly NOM-137 for labeling and NOM-241 for GMP.
• USMCA/T-MEC provisions: The US-Mexico-Canada trade agreement provides preferential terms for qualifying North American-manufactured devices.
• Price references: IMSS uses reference pricing from previous procurements. Dramatic price increases between procurement cycles face scrutiny.

Market size and opportunity

• IMSS hospital modernization: Large-scale equipment replacement programs across IMSS hospitals.
• Nearshoring benefits: Mexico's nearshoring trend attracts medical device manufacturing investment, creating partnership and supply chain opportunities.
• Chronic disease management: High rates of diabetes and cardiovascular disease drive demand for monitoring and treatment devices.
• Private sector growth: Mexico's growing middle class is driving private healthcare utilization and device adoption.

Tips for foreign suppliers

1. Target IMSS procurement: IMSS consolidated purchasing provides the highest-volume single-customer opportunity. Understand IMSS procurement cycles and bidding requirements.
2. Leverage USMCA: If manufacturing in North America, USMCA tariff benefits provide pricing advantages over non-NAFTA competitors.
3. Invest in COFEPRIS relationships: Proactive engagement with COFEPRIS reviewers and complete initial submissions significantly reduce registration timelines.
4. Build Spanish-language capabilities: From regulatory submissions to clinical training, Spanish fluency is essential for the Mexican market.
5. Monitor CompraNet systematically: IMSS, ISSSTE, and state-level tenders create a steady stream of opportunities. MedStrato tracks Mexican public procurement across all entities. Book a demo to learn more.